Showing results (1121-1130 of 5,058) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|February 1, 2024
Examining dietary habits in the context of multiple sclerosis: A comprehensive investigative approachBüşra Atabilen, Yasemin Akdevelioğlu, Pınar Acar Özen, et al.
Multiple Sclerosis and Related Disorders|August 3, 2023
Empathize with the well patientScott Dunham
Multiple Sclerosis and Related Disorders|July 28, 2023
Associations between Social Support and Cognitive Performance among Persons with MSCaroline M Rafizadeh, Cheyenne Smith, Lauren B Strober, et al.
Multiple Sclerosis and Related Disorders|July 27, 2023
Stress indicators in minorities with multiple sclerosisEvelyn A Hunter, J M Meyer, G M Brown, et al.
Multiple Sclerosis and Related Disorders|July 29, 2023
Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled studySeyed Massood Nabavi, Shahedeh Karimi, Leila Arab, et al.
Multiple Sclerosis and Related Disorders|July 24, 2023
Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world dataLilyana Amezcua, Terrie Livingston, Brooke Hayward, et al.
Multiple Sclerosis and Related Disorders|March 20, 2026
Do sleep interventions improve sleep in MS? A systematic review and meta-analysis of activity monitor assessed outcomesTadeg Jemere, Ingrid van der Mei, Cynthia Honan, et al.
Multiple Sclerosis and Related Disorders|December 12, 2025
Influence of FCGR2A (rs1801274) and FCGR3A (rs396991) polymorphisms on natalizumab response on multiple sclerosisRafaella de C Cardoso, Matheus D de Matos, Larissa A Duarte, et al.
Multiple Sclerosis and Related Disorders|April 9, 2026
Twelve-week intermittent hypoxia intervention in multiple sclerosis - A safety and feasibility trialCharlotte Schubert, Anna Suling, Caren Ramien, et al.
Multiple Sclerosis and Related Disorders|March 18, 2026
Effect of Dalfampridine on cognition, gait and fatigue in patients with multiple sclerosis: a randomized placebo-controlled studyMai Mohamed Elsayed Abdeldayem, Azza Abdelnasser, Salma Hamed Khalil, et al.
Pageof 506